Tonix Pharmaceuticals Holding Corp. buy Noble Financial
Start price
20.03.25
/
50%
€2.82
Target price
20.03.26
€64.19
Performance (%)
-
End price
21.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % |
Comments by Noble_Financial for this prediction
In the thread Tonix Pharma. Holding Corp. diskutieren
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
Ratings data for TNXP provided by MarketBeat
In the thread Trading Tonix Pharmaceuticals Holding Corp.
Die von Noble_Financial gewählte maximale Laufzeit wurde überschritten